Stock BINDQ DNIB UNWIND INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company DNIB Unwind Inc OTC Bulletin Board

Equities

BINDQ

US05548N1072

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for DNIB Unwind Inc

Managers

Managers TitleAgeSince
Stephen Zale CTO
 Chief Tech/Sci/R&D Officer 68 06-10-31
Tom Baker IRC
 Investor Relations Contact - -
Neil Bander PRN
 Corporate Officer/Principal - -
Geoffrey L. Berman PRN
 Corporate Officer/Principal - 16-07-23
James L. Wright PRN
 Corporate Officer/Principal 76 06-12-31

Members of the board

Members of the board TitleAgeSince
Geoffrey L. Berman PRN
 Corporate Officer/Principal - 16-07-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,886,802 17,860,424 ( 85.51 %) 0 85.51 %

Company contact information

DNIB Unwind, Inc.

333 South Grand Avenue Suite 4100

90071, Los Angeles

+617-491-3400

http://bindtherapeutics.com
address DNIB Unwind Inc(BINDQ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.17% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.87% 96.09B
ARGENX SE Stock argenx SE
+2.13% 22.28B
BIONTECH SE Stock BioNTech SE
-14.77% 21.4B
GENMAB A/S Stock Genmab A/S
-8.79% 18.14B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.02B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.09B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+8.55% 13.83B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.75% 11.97B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. BINDQ Stock
  4. BINDQ Stock
  5. Company DNIB Unwind Inc